Market News AIOpen the app

NXG stock news · NexgenRx Inc.

Stories about NexgenRx Inc. (NXG) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NXG

Follow NexgenRx Inc. (NXG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NXG
Free on the App Store and Google Play, or on the web.
  1. Nov 20, 2026, 9:09 AM ET · Market

    NexgenRx shared its Q3 2026 results, with revenues up 8% and a big jump in income before taxes.

    Good for NXG

    NexgenRx's Q3 sales rose 8% to $4.9 million. EBITDA rose 18.1% to $1,048,210, but a $907,728 tax charge caused a $63,993 loss.